1-5 of 5
Yunkai Yu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy

Daniel M. Girardi, Scot A. Niglio, Amir Mortazavi, Rosa Nadal, Primo Lara, Sumanta K. Pal, Biren Saraiya, Lisa Cordes, Lisa Ley, Olena Sierra Ortiz, Jacqueline Cadena, Carlos Diaz, Hadi Bagheri, Bernadette Redd, Seth M. Steinberg, Rene Costello, Keith S. Chan, Min-Jung Lee, Sunmin Lee, Yunkai Yu, Sandeep Gurram, Heather J. Chalfin, Vladimir Valera, William D. Figg, Maria Merino, Antoun Toubaji, Howard Streicher, John J. Wright, Elad Sharon, Howard L. Parnes, Yang-Min Ning, Donald P. Bottaro, Liang Cao, Jane B. Trepel, Andrea B. Apolo
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (7): 1353–1362.
https://doi.org/10.1158/1078-0432.CCR-21-3726
Published: 01 April 2022
View article titled, Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy
Open the PDF for Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy in another window
Includes: Supplementary data
Journal Articles

Phase I and Preliminary Phase II Study of TRC105 in Combination with Sorafenib in Hepatocellular Carcinoma

Austin G. Duffy, Chi Ma, Susanna V. Ulahannan, Osama E. Rahma, Oxana Makarova-Rusher, Liang Cao, Yunkai Yu, David E. Kleiner, Jane Trepel, Min-Jung Lee, Yusuke Tomita, Seth M. Steinberg, Theo Heller, Baris Turkbey, Peter L. Choyke, Cody J. Peer, William D. Figg, Brad J. Wood, Tim F. Greten
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (16): 4633–4641.
https://doi.org/10.1158/1078-0432.CCR-16-3171
Published: 14 August 2017
View article titled, Phase I and Preliminary Phase II Study of TRC105 in Combination with Sorafenib in Hepatocellular Carcinoma
Open the PDF for Phase I and Preliminary Phase II Study of TRC105 in Combination with Sorafenib in Hepatocellular Carcinoma in another window
Includes: Supplementary data
Journal Articles

Drozitumab, a Human Antibody to Death Receptor 5, Has Potent Antitumor Activity against Rhabdomyosarcoma with the Expression of Caspase-8 Predictive of Response

Zhigang Kang, Jun-Jie Chen, Yunkai Yu, Bo Li, Shi-Yong Sun, Baolin Zhang, Liang Cao
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (10): 3181–3192.
https://doi.org/10.1158/1078-0432.CCR-10-2874
Published: 15 May 2011
View article titled, Drozitumab, a Human Antibody to Death Receptor 5, Has Potent Antitumor Activity against Rhabdomyosarcoma with the Expression of Caspase-8 Predictive of Response
Open the PDF for Drozitumab, a Human Antibody to Death Receptor 5, Has Potent Antitumor Activity against Rhabdomyosarcoma with the Expression of Caspase-8 Predictive of Response in another window
Includes: Supplementary data
Journal Articles

Evaluation of KRAS Mutations, Angiogenic Biomarkers, and DCE-MRI in Patients with Advanced Non–Small-Cell Lung Cancer Receiving Sorafenib

Ronan J. Kelly, Arun Rajan, Jeremy Force, Ariel Lopez-Chavez, Corrine Keen, Liang Cao, Yunkai Yu, Peter Choyke, Baris Turkbey, Mark Raffeld, Liqiang Xi, Seth M. Steinberg, John J. Wright, Shivaani Kummar, Martin Gutierrez, Giuseppe Giaccone
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (5): 1190–1199.
https://doi.org/10.1158/1078-0432.CCR-10-2331
Published: 01 March 2011
View article titled, Evaluation of KRAS Mutations, Angiogenic Biomarkers, and DCE-MRI in Patients with Advanced Non–Small-Cell Lung Cancer Receiving Sorafenib
Open the PDF for Evaluation of KRAS Mutations, Angiogenic Biomarkers, and DCE-MRI in Patients with Advanced Non–Small-Cell Lung Cancer Receiving Sorafenib in another window
Includes: Supplementary data
Journal Articles

A Phase II Clinical Trial of Sorafenib in Androgen-Independent Prostate Cancer

William L. Dahut, Charity Scripture, Edwin Posadas, Lokesh Jain, James L. Gulley, Philip M. Arlen, John J. Wright, Yunkai Yu, Liang Cao, Seth M. Steinberg, Jeanny B. Aragon-Ching, Jürgen Venitz, Elizabeth Jones, Clara C. Chen, William D. Figg
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (1): 209–214.
https://doi.org/10.1158/1078-0432.CCR-07-1355
Published: 02 January 2008
View article titled, A Phase II Clinical Trial of Sorafenib in Androgen-Independent Prostate Cancer
Open the PDF for A Phase II Clinical Trial of Sorafenib in Androgen-Independent Prostate Cancer in another window